Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Kinaxis Inc KXSCF


Primary Symbol: T.KXS

Kinaxis Inc. is a Canada-based company that is engaged in the design, development, marketing and sale of supply chain management software and solutions. The Company provides cloud-based subscription software that enables its customers to improve analysis and decision-making across their supply chain operations. The Company's cloud-based supply chain management platform is RapidResponse. Its... see more

TSX:KXS - Post Discussion

Kinaxis Inc > TD Notes
View:
Post by retiredcf on Mar 13, 2023 9:09am

TD Notes

Expecting Immaterial Impact from SVB Collapse

Event

While regulators are backstopping SVB, we consider our coverage's exposure to the bank. Most of our coverage has no direct ties with SVB and those that do have minimal exposure. If any challenges arise from this event, there could be M&A opportunities for many Canadian technology companies given their strong balance sheets.

Impact: NEUTRAL

Likely immaterial impact to our coverage. Few companies in our coverage have direct business with SVB, but those that do are not expected to be materially impacted.

  • Shopify - Very minor impact expected. A small portion of funds and U.S.-based operations tied to SVB.

  • Lightspeed - Single-digit millions exposure of its $838mm in net cash. SVB was used for some payroll operations.

  • BlackBerry - A few legacy accounts, with a small balance, from acquisitions.

  • WELL Health - Circle Medical (58% owned) has some exposure. Immaterial to WELL.

  • Coveo - (Very) small and immaterial exposure.

  • D2L - Small and immaterial exposure.

    Secondary effects likely manageable. The indirect impact to our covered companies is much more difficult to assess.

  • Customers - Given SVB's focus on the tech sector, we believe companies that have a large technology customer base are at a higher risk, especially ones focused on the SMB/mid-market (we assume most Enterprise customers have low/no direct SVB-related risk). Companies may increase bad debt expenses to reflect increased credit risk.

  • Channel partners - Challenges at channel partners could be disruptive in the near-term; however, we assume their customers would switch to a competitor or go direct.

  • Suppliers - We are currently unaware of any (smaller) software/hardware vendor or strategic partner (e.g., manufacturing) utilized by our covered companies that has been materially impacted by SVB's collapse.

    Potential silver lining for Canadian tech. Companies with a strong balance sheet and minimal exposure to SVB could acquire some attractive technology/businesses if challenges drive lower valuations. Those that we would highlight with a greater likelihood for acquisitions given their strategy and/or recent management comments are Altus, CGI, Converge, Coveo, Descartes, Dialogue, Docebo, Enghouse, Kinaxis, and Softchoice.

     
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities